Integral Derivatives’s Gilead Sciences GILD Stock Holding History

Integral Derivatives’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$2.35M	Buy	31,187 +22,443	+257%	+$1.78M	0.06%	104
2017 Q4	$626K	Sell	8,744 -29,413	-77%	-$2.23M	0.01%	652
2017 Q3	$3.09M	Sell	38,157 -15,147	-28%	-$1.16M	0.06%	216
2017 Q2	$3.77M	Sell	53,304 -4,066	-7%	-$271K	0.08%	154
2017 Q1	$3.9M	Buy	57,370 +19,673	+52%	+$1.38M	0.07%	176
2016 Q4	$2.7M	Buy	37,697 +9,649	+34%	+$717K	0.05%	248
2016 Q3	$2.22M	Buy	28,048 +14,892	+113%	+$1.21M	0.05%	245
2016 Q2	$1.1M	Sell	13,156 -21,523	-62%	-$1.91M	0.03%	391
2016 Q1	$3.19M	Buy	+34,679	New	+$3.13M	0.1%	142
2015 Q4	–	Sell	-10,142	Closed	-$1.06M	–	1120
2015 Q3	$996K	Sell	10,142 -75,490	-88%	-$8.38M	0.03%	499
2015 Q2	$10M	Buy	+85,632	New	+$9.36M	0.27%	59
2015 Q1	–	Sell	-27,866	Closed	-$2.83M	–	1196
2014 Q4	$2.63M	Sell	27,866 -27,171	-49%	-$2.81M	0.05%	350
2014 Q3	$5.86M	Buy	55,037 +15,351	+39%	+$1.5M	0.1%	161
2014 Q2	$3.29M	Buy	39,686 +30,231	+320%	+$2.35M	0.06%	270
2014 Q1	$670K	Buy	9,455 +5,409	+134%	+$424K	0.01%	793
2013 Q4	$304K	Buy	+4,046	New	+$282K	﹤0.01%	1209

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Integral Derivatives's GILD Position: Q1 2018 in Review

Integral Derivatives increased its Gilead Sciences (GILD) stake by 257% in Q1 2018, buying an estimated $1.78M and bringing the position to 31,187 shares worth $2.35M. The position accounts for 0.06% of the portfolio, ranked #104.

Integral Derivatives first reported a position in GILD in Q4 2013 and has held it in 16 quarters since. The position peaked at $10M in Q2 2015. 1,564 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

Integral Derivatives held 31,187 shares of Gilead Sciences worth $2.35M as of Q1 2018.
Integral Derivatives bought 22,443 Gilead Sciences shares in Q1 2018, an estimated $1.78M.
Gilead Sciences made up 0.06% of Integral Derivatives's portfolio in Q1 2018, its #104 holding.
Integral Derivatives first reported a position in Gilead Sciences in Q4 2013 and has held it in 16 quarters since.
Integral Derivatives's Gilead Sciences position peaked at $10M in Q2 2015.
1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.